Effects of cyclic phosphatidic acid on delayed neuronal death following transient ischemia in rat hippocampal CA1

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 206-209

  Gotoh, Mari ^a   Hotta, Harumi ^b   Murakami Murofushi, Kimiko ^a  

^a OCHANOMIZU UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Blood brain barrier; Cyclic phosphatidic acid; Hippocampus; Ischemia induced delayed neuronal death; Systemic administration

Indexed keywords

2 O CARBA OLEOYL CYCLIC PHOSPHATIDIC ACID; BOVINE SERUM ALBUMIN; CYCLIC PHOSPHATIDIC ACID; PHOSPHATIDIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; VERTEBRAL ARTERY LIGATION;

ANIMALS; CA1 REGION, HIPPOCAMPAL; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INFUSIONS, SUBCUTANEOUS; ISCHEMIC ATTACK, TRANSIENT; LIPID METABOLISM; MALE; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHATIDIC ACIDS; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RECEPTORS, LYSOPHOSPHATIDIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 78049255263     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.052     Document Type: Article

References (23)

1. Abe K. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J. Cereb. Blood Flow Metab. 2000, 20:1393-1408.
2. Baker D.L., Fujiwara Y., Pigg K.R., Tsukahara R., Kobayashi S., Murofushi H., Uchiyama A., Murakami-Murofushi K., Koh E., Bandle R.W., Byun H.-S., Bittman R., Fan D., Murph M., Mills G.B., Tigyi G. Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotoxin and cancer cell invasion and metastasis. J. Biol. Chem. 2006, 281:22786-22793.
3. Blondeau N., Lauritzen I., Widmann C., Lazdunski M., Heurteaux C. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J. Cereb. Blood Flow Metab. 2002, 22:821-834.
4. Chen M., Towers L.N., O'Connor K.L. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Am. J. Physiol. Cell Physiol. 2007, 292:C1927-C1933.
5. Deng W., E.S., Tsukahara R., Valentine W.J., Durgam G., Gududuru V., Balazs L., Manickman V., Arsura M., Vanmiddlesworth L., Johnson L.R., Parrill A.L., Miller D.D., Tigyi G. Lysophosphatidic acid type2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology 2007, 132:1834-1851.
6. Fujiwara Y. Cyclic phosphatidic acid-a unique bioactive phospholipid. Biochim. Biophys. Acta 2008, 1781:519-524.
7. Fujiwara Y., Sebök A., Meakin S., Kobayashi T., Murakami-Murofushi K., Tigyi G. Cyclic phosphatidic acid elicits neurotrophin-like actions in embryonic hippocampal neurons. J. Neurochem. 2003, 87:1272-1283.
8. Hotta H., Kagitani F., Murakami-Murofushi K. Cyclic phosphatidic acid stimulates respiration without producing vasopressor or tachycardiac effects in rats. Eur. J. Pharm. 2006, 543:27-31.
9. Kagitani F., Uchida S., Hotta H., Sato A. Effect of nicotine on blood flow and delayed neuronal death following intermittent transient ischemia in rat hippocampus. Jpn. J. Physiol. 2000, 50:585-595.
10. Kobayashi S., Tokunoh R., Shibasaki M., Shinagawa R., Murakami-Murofushi K. Synthesis of 1-O-acylgrycerol 2, 3-cyclic phosphate: determination of the absolute structure of PHYLPA, a specific inhibitor of DNA polymerase α. Tetrahedron Lett. 1993, 34:4047-4050.
11. Mukai M., Imamura F., Ayaki M., Shinkai K., Iwasaki T., Murakami-Murofushi K., Murofushi H., Kobayashi S., Yamamoto T., Nakamura H., Akedo H. Inhibition of tumor invasion and metastasis by a novel lysophophatidic acid (cyclic LPA). Int. J. Cancer 1999, 81:918-922.
12. Murakami M., Shiraishi A., Tabata K., Fujita N. Identification of the orphan GPCR, P2Y10 receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. Biophys. Res. Commun. 2008, 371:707-712.
13. Murakami-Murofushi K., Shioda M., Kaji K., Yoshida S., Murofushi H. Inhibition of eukaryotic DNA polymerase alpha with a novel lysophosphatidic acid (PHYLPA) isolated from myxoamoebae Physarum polycephalum. J. Biol. Chem. 1992, 267:21512-21517.
14. Murakami-Murofushi K., Uchiyama A., Fujiwara Y., Kobayashi T., Kobayashi S., Mukai M., Murofushi H., Tigyi G. Biological functions of a novel lipid mediator, cyclic phosphatidic acid. Biochim. Biophys. Acta 2002, 1582:1-7.
15. 3 receptors reduces murine renal ischemia-reperfusion injury. Am. J. Physiol. Renal. Physiol. 2003, 285:565-574.
16. Pasternack S.M., von Kügelgen I., Aboud K.A., Lee Y.-A., Rüschendorf F., Voss K., Hillmer A.M., Molderings G.J., Franz T., Ramirez A., Nürnberg P., Nöthen M.M., Betz R.C. G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat. Genet. 2008, 363:861-866.
17. Savitz S.I., Dhallu M.S., Malhotra S., Mammis A., Ocava L.C., Rosenbaum P.S., Rosenbaum D.M. EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion injury. Brain Res. 2006, 1118:168-175.
18. Shigeno T., Mima T., Takakura K., Graham D.I., Kato G., Hashimoto Y., Furukawa S. Amilioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 1991, 11:2914-2919.
19. Tabata K., Baba K., Shiraishi A., Ito M., Fujita N. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun. 2007, 363:861-866.
20. Tsuda S., Okudaira S., Moriya-Ito K., Shimamoto C., Tanaka M., Aoki J., Arai H., Murakami-Murofushi K. Cyclic phosphatidic acid is produced by autotaxin in blood. J. Biol. Chem. 2006, 281:26081-26088.
21. Uchiyama A., Mukai M., Fujiwara Y., Kobayashi S., Kawai N., Murofushi H., Inoue M., Enoki S., Tanaka Y., Niki T., Kobayashi T., Tigyi G., Murakami-Murofushi K. Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid. Biochim. Biophys. Acta 2007, 1771:103-112.
22. Williams J.R., Khandoga A.L., Goyal P., Fells J.I., Perygin D.H., Siess W., Parrill A.L., Tigyi G., Fujiwara Y. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J. Biol. Chem. 2009, 284:17304-17319.
23. Xie Y., Ye L., Zhaang X., Cui W., Lou J., Nagai T., Hou X. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies. J. Control. Release 2005, 105:106-119.